Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$63,430,658
+$23,993,682 QoQ
Shares Held
52,884
+23.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#488
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2024CallValue
$210,400
CallShares
8,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $290,206,318 across 12 Drug Manufacturers - General names. LLY ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
411,773 | $78,080,395 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
52,884 | $63,430,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
399,582 | $51,346,286 | |
| 4 | PFE |
Pfizer Inc
|
1,455,651 | $35,052,075 | |
| 5 | JNJ |
Johnson & Johnson
|
78,892 | $20,036,200 | |
| 6 | ABBV |
AbbVie Inc.
|
49,869 | $12,549,032 | |
| 7 | BIIB |
Biogen Inc.
|
56,064 | $12,113,187 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
83,510 | $10,550,651 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,430,658 | 52,884 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $39,436,976 | 42,877 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $47,151,587 | 43,875 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $40,553,450 | 53,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $41,455,403 | 53,180 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $51,130,432 | 61,908 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $79,675,032 | 103,206 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $92,099,661 | 103,957 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $90,632,154 | 100,104 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $210,400 | 8,000 | Call | Sole | 2024-05-08 | |
| 2024-03-31 | $43,866,829 | 56,387 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $48,750 | 15,000 | Call | Sole | 2024-02-12 | |
| 2023-12-31 | $31,791,290 | 54,538 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $44,489,403 | 82,828 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $37,642,679 | 80,265 | Shares | Sole | 2023-08-09 | |
| 2023-06-30 | $206,500 | 17,500 | Call | Sole | 2023-08-09 | |
| 2023-03-31 | $22,148,872 | 64,495 | Shares | Sole | 2023-05-11 | |
| 2023-03-31 | $204,100 | 13,000 | Call | Sole | 2023-05-11 | |
| 2022-12-31 | $24,964,189 | 68,238 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $97,000 | 4,000 | Call | Sole | 2022-11-09 | |
| 2022-09-30 | $20,682,435 | 63,963 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $22,449,360 | 69,239 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $24,728,049 | 86,350 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $25,956,669 | 93,971 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $25,348,726 | 109,711 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $25,952,514 | 113,073 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $21,012,205 | 112,473 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,520,346 | 127,460 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,440,600 | 30,000 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||